PubRank

Stefan Ståhl

Author PubWeight™ 52.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res 2006 2.46
2 Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation. Proc Natl Acad Sci U S A 2008 1.99
3 Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry. J Nucl Med 2009 1.54
4 Display of proteins on bacteria. J Biotechnol 2002 1.48
5 Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule. J Mol Biol 2008 1.19
6 Epitope mapping of antibodies using bacterial surface display. Nat Methods 2008 1.18
7 Biotechnological applications for surface-engineered bacteria. Biotechnol Appl Biochem 2004 1.17
8 Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues. Mol Cell Proteomics 2003 1.15
9 Non-immunoglobulin based protein scaffolds. Curr Opin Biotechnol 2011 1.14
10 Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli. Biotechnol Appl Biochem 2002 1.10
11 Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides. J Biotechnol 2006 1.07
12 Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule. Nucl Med Biol 2007 1.06
13 Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo. PLoS Biol 2010 1.05
14 In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics. Cancer Biother Radiopharm 2005 1.03
15 Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice. Eur J Nucl Med Mol Imaging 2006 1.02
16 Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. J Nucl Med 2006 0.99
17 Engineered affinity proteins--generation and applications. J Biotechnol 2009 0.95
18 Engineered affinity proteins for tumour-targeting applications. Biotechnol Appl Biochem 2009 0.95
19 Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification. PLoS One 2013 0.94
20 A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry. Protein Eng Des Sel 2008 0.93
21 Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule. Biotechnol Appl Biochem 2009 0.92
22 Exploring epitopes of antibodies toward the human tryptophanyl-tRNA synthetase. N Biotechnol 2009 0.92
23 Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules. Protein Eng Des Sel 2010 0.91
24 Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro. Biotechnol Appl Biochem 2009 0.91
25 Cellular effects of HER3-specific affibody molecules. PLoS One 2012 0.91
26 Fine affinity discrimination by normalized fluorescence activated cell sorting in staphylococcal surface display. FEMS Microbiol Lett 2005 0.91
27 Molecular design and optimization of 99mTc-labeled recombinant affibody molecules improves their biodistribution and imaging properties. J Nucl Med 2011 0.89
28 Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2. Bioconjug Chem 2012 0.87
29 Evaluation of staphylococcal cell surface display and flow cytometry for postselectional characterization of affinity proteins in combinatorial protein engineering applications. Appl Environ Microbiol 2007 0.86
30 Selection and characterization of an HIV-1 gp120-binding affibody ligand. Biotechnol Appl Biochem 2006 0.85
31 Approaches for systematic proteome exploration. Biomol Eng 2007 0.85
32 Vector engineering to improve a staphylococcal surface display system. FEMS Microbiol Lett 2002 0.85
33 Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for 99mTc-labelling at the C terminus. Tumour Biol 2012 0.85
34 Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension. Biotechnol J 2014 0.84
35 Surface display of a single-domain antibody library on Gram-positive bacteria. Cell Mol Life Sci 2012 0.84
36 Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms. Vet Parasitol 2005 0.84
37 HER2-positive tumors imaged within 1 hour using a site-specifically 11C-labeled Sel-tagged affibody molecule. J Nucl Med 2012 0.83
38 Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene. Vaccine 2005 0.82
39 Engineering streptococcal protein G for increased alkaline stability. Protein Eng 2002 0.81
40 An improved dual-expression concept, generating high-quality antibodies for proteomics research. Biotechnol Appl Biochem 2003 0.80
41 Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule. Eur J Nucl Med Mol Imaging 2014 0.80
42 Generation of Affibody ligands binding interleukin-2 receptor alpha/CD25. Biotechnol Appl Biochem 2008 0.80
43 General strategies for efficient adjuvant incorporation of recombinant subunit immunogens. Vaccine 2005 0.79
44 Engineering of staphylococcal surfaces for biotechnological applications. J Biotechnol 2002 0.79
45 Affibody-mediated transferrin depletion for proteomics applications. Biotechnol J 2007 0.79
46 Epitope mapping using gram-positive surface display. Curr Protoc Immunol 2010 0.79
47 Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations. Vaccine 2007 0.78
48 Simplified characterization through site-specific protease-mediated release of affinity proteins selected by staphylococcal display. FEMS Microbiol Lett 2007 0.78
49 Construction and characterization of affibody-Fc chimeras produced in Escherichia coli. J Immunol Methods 2002 0.78
50 Staphylococcal surface display in combinatorial protein engineering and epitope mapping of antibodies. Recent Pat Biotechnol 2010 0.78
51 A novel affinity gene fusion system allowing protein A-based recovery of non-immunoglobulin gene products. J Biotechnol 2002 0.78
52 Fluorescence-activated cell sorting of specific affibody-displaying staphylococci. Appl Environ Microbiol 2003 0.77
53 Staphylococcal display for combinatorial protein engineering of a head-to-tail affibody dimer binding the Alzheimer amyloid-β peptide. Biotechnol J 2012 0.77
54 Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand. Protein Expr Purif 2010 0.77
55 Achieving directed immunostimulating complexes incorporation. Expert Rev Vaccines 2006 0.77
56 Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules. Amino Acids 2011 0.76
57 Design and evaluation of radiolabeled tracers for tumor imaging. Biotechnol Appl Biochem 2013 0.75
58 Single-vector three-frame expression systems for affinity-tagged proteins. FEMS Microbiol Lett 2002 0.75
59 A high-stringency proteomics concept aimed for generation of antibodies specific for cDNA-encoded proteins. Biotechnol Appl Biochem 2002 0.75
60 General expression vectors for Staphylococcus carnosus enabled efficient production of the outer membrane protein A of Klebsiella pneumoniae. FEMS Microbiol Lett 2002 0.75
61 Applying biotin-streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens. Biotechnol Appl Biochem 2005 0.75